diagnostics development News
-
Crain`s Business Chicago Feature on NoMo Diagnostics
“NoMo Diagnostics is developing what it hopes will be the first FDA-approved, real-time concussion detector to facilitate early recognition and ...
-
Gene for Brain Connections Linked with Autism
Reuters – March 19, 2008 – Health and Science article featuring Population Diagnostics cofounder Dr. Hatchwell’s discovery of autism gene Contactin 4 (CNTN4) [Journal of Medical Genetics paper]; cites Population Diagnostics is developing early detection tests for autism and other genetic diseases Full story ...
-
Eg Technology Launch Free Diagnostics EBook And Supporting Gap Analysis
The free eBook has been created as a tool to help organisations identify common areas of concern within any diagnostics development programme and help create a refined development roadmap, ensuring complete end-to-end project visibility and a streamlined route to market. The Covid 19 pandemic has had a noticeable impact on the MedTech landscape, specifically within the field of diagnostics. As ...
-
Dako, an Agilent Technologies Company, Announces Expanded Collaboration with Amgen Within Companion Diagnostics
Dako, an Agilent Technologies company and a worldwide provider of cancer diagnostics, today announced a new Master Collaboration Agreement with Amgen Inc., a leading biotechnology company. The expanded collaboration will allow both companies to benefit from knowledge-sharing within the field of drug-diagnostic research and development in general, and in relation to companion diagnostic products ...
-
Vybion receives $1.3M subcontract to develop diagnostics for Lassa Virus
Vybion has received a $1.3M subcontract on at $7.1M NIH Cooperative Agreement to develop diagnostics for Lassa Virus, a deadly hemorrhagic virus endemic in West Africa. Researchers at Tulane University, in collaboration with Corgenix Medical Corporation, a worldwide developer and marketer of diagnostic test kits, have received a five-year $7.07 million grant from the National Institutes of Health ...
By Vybion
-
GeneCentric Therapeutics Collaborates with Labcorp to Develop Novel RNA-Based Oncology Diagnostics
DURHAM, N.C. – October 12, 2021 — GeneCentric Therapeutics, a company making precision medicine more precise through RNA-based diagnostics, today announced a new strategic collaboration with Labcorp, a leading global life sciences company, to develop and commercialize new RNA-based gene signatures as diagnostics for people with cancer. This latest collaboration builds on the ...
-
D-Kimia expands to further support North American Market
D-Kimia Diagnostic Solutions announces the opening of its offices in New York to support its growing partnerships with US diagnostic labs and further develop its companion testing solutions with major anti-viral treatments. Hepatitis C (HCV) affects an estimated 5 million Americans and there is a growing concern of a much larger undiagnosed population. The CDC now recommends all baby boomers ...
By D-Kimia, LLC
-
Medical today - Theramx, Exports ‘EG-Q Bond’, a Topical Skin Adhesive for epidermal bonding, to Spain(Europe)
Theramx announced on the 14th that it has signed an annual export contract with the Madrid Regional Health Agency, Spain, and has completed the delivery of the product. The product exported to Spain is EG-Q Bond, a bioadhesive for epidermal bonding that joins the affected area without using a separate suture for 20,000 endoscopic and laparoscopic surgeries. A Theramx official said, ...
By Theramx Inc.
-
Showcase
New device offers a mouthful of data for chronic diseases
Aidar Health, formerly known as Multisensor Diagnostics, has developed a portable hand-held device that allows patients to measure and track vital signs in a matter of seconds. Roughly the size of an iPhone, MouthLab consists of a hand unit and a mouthpiece that fits between the teeth and lips. The mouthpiece uses special sensors to gather information from breathing patterns, saliva and blood ...
By Aidar Health
-
Our Partnership with Cerba HealthCare
The Cerba HealthCare Group and METAFORA biosystems are to cooperate in the deployment of METAFORA proprietary technology in the field of metabolomics for diagnostics purposes. The technological platform developed by METAFORA enables the evaluation of cells’ energy needs in connection with patients’ health. “The investigation into altered metabolic functions for the ...
-
Vela Diagnostics Announces Development of New Test Kit for Detection of Wuhan Coronavirus
Vela Diagnostics has announced the development of the ViroKey SA201 2019-nCoV RT-PCR Test, a new test kit for the detection of the 2019 Novel Coronavirus (2019-nCoV), otherwise known as the Wuhan Coronavirus. The Wuhan Coronavirus was first identified in mid-December 2019 in Wuhan, China. Human-to-human transmission has been confirmed by China’s health ministry. According to Chinese health ...
-
Specific Diagnostics Announces the Creation of a European Warehouse and Servicing Center
Specific Diagnostics today announces the opening of its European warehouse and servicing center in Amsterdam, Netherlands, to support its growing European operations. Working with global integrated logistics leader Crane Worldwide Logistics, Specific and its European subsidiary Specific Diagnostics Europe, Ltd., will warehouse Reveal® instruments and consumables in the Amsterdam facility. The ...
-
HTI announces Dr. Jeff King as Senior Advisor
Health Technology Innovations, Inc. (HTI) today announced that Dr. Jeff King is joining HTI as a Senior Advisor. Dr. King is CEO and co-founder of Virogenomics BioDevelopment, Inc. (VBD), a biotechnology research and development company that collaborates extensively with scientists at Oregon Health and Science University (OHSU) who are developing technology with potential commercial applications. ...
-
Biosceptre Wins Funding from the UK Government-Backed, SMART Award to Develop Novel Cancer Diagnostic and Therapeutic Targets
Cambridge, UK, 8th February 2016 – Biosceptre, a biopharmaceutical company developing innovative diagnostic and therapeutic approaches to cancer, today announced that the UK government-backed Innovate UK SMART award scheme, has awarded the company £100,000 to support pre-clinical development of diagnostic approaches and antibodies to target Kidney and Lung cancers. This project will ...
-
Weekly Donga - EG-Q, Wound Care Liquid Band, Ranked No.1 in Consumer Preference in Korea
EG-Q won the '2022 Korea Consumer Preference No. 1' medical device (liquid band) category. '2022 Korea's No. 1 Consumer Preference' was established to provide consumers with an opportunity to receive verified services and the right selection criteria by discovering and awarding companies, products, and brands that have been verified through fair research. EG-Q is a brand specializing in ...
By Theramx Inc.
-
Unbiased gene fusion analysis required in future cancer diagnostics
Today about 20 cancer treatments approved by FDA and EMA are directed towards specific gene fusions, and the number of drugs available is growing annually. The increased importance of gene fusions in oncology is driving demand from diagnostic laboratories for scalable analytical solutions. RNA can be used to analyze gene fusions. Moreover, while DNA is largely identical in all cells, RNA ...
By Qlucore AB
-
Former Genmark Senior Vice President Scott O’Brien Joins Specific Diagnostics as Chief Commercial Officer
Specific Diagnostics today announced the appointment of Scott O’Brien as its Chief Commercial Officer. Mr. O’Brien is an industry veteran with over 20 years in molecular and infectious disease diagnostics, the last 10 at GenMark where he held a range of commercial positions, most recently Senior Vice President Global Marketing and International Sales at GenMark Diagnostics, ...
-
Coremap Completes $10.5 Million Series A Financing
CoreMap announced today it has completed a $10.5 million Series A financing led by Qure Ventures. The round included both existing investors such as Ronny Ginor, MD of Fifth Focus/HRMG Investments and Orbimed Venture Partners, and a diverse group of new strategic, corporate and financial partners. CoreMap was founded in 2016 by Dr. Peter Spector and based on his groundbreaking work concerning the ...
By CoreMap Inc.
-
Specific Diagnostics Announces the Formation of its US Commercial Team and Introduction of the Reveal Rapid AST System to the US Market
Specific Diagnostics today announced formation of its US commercial sales, service, support and marketing teams in anticipation of the launch of the Reveal Rapid AST System for blood infection samples. Following 11 studies across France and England comprising over 1,400 clinical positive blood culture samples, yielding overall accuracy of 97.8%, and in tandem with the commencement of clinical and ...
-
Dako, an Agilent Technologies Company, and U.S.-based Merck & Co. to Collaborate on Companion Diagnostic Test for Analysis of Tumor PD-L1 Levels
Dako, an Agilent Technologies company and a worldwide provider of cancer diagnostics, today announced a collaboration with Merck & Co., Inc. (known as MSD outside the United States and Canada, through an affiliate) to develop a companion diagnostic test for the analysis of the potential tumor biomarker PD-L1 to aid in the treatment of cancer. The companion diagnostic test coming out of this ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you